KRAS and neoplasm: Initially, KRAS was associated with a favorable response to ICPI, as it was more frequently associated with smokers, high tumor mutational burden (TMB) and enhanced PD-L1, as well as high infiltration of immune cells (TILs) (13, 29, 30).